Centene Outperformed Despite Higher Medicaid Acuity -- Market Talk

Dow Jones10-25

1006 ET - Centene logged better 3Q earnings than analysts had expected despite seeing higher-than-expected acuity--a measure of illness severity--in its Medicaid patient population after redeterminations, Mizuho analyst Ann Hynes says in a research note. The company's strong position in the individual marketplace continues to offset these Medicaid pressures, the analyst says. The managed healthcare provider delivered a solid quarter in contrast to its peers' results, which seem to have spooked investors, Hynes says. Centene's stock fell 23% between Sept. 1 and this morning's earnings release. Cost trends will be a main focus of management's call with analysts, Hynes says. Shares rise 11% to $68.53. (dean.seal@wsj.com)

(END) Dow Jones Newswires

October 25, 2024 10:06 ET (14:06 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2478365389?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-25 22:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478365389","market":"nz","top_or_hot":-1,"title":"Centene Outperformed Despite Higher Medicaid Acuity -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1006 ET - Centene logged better 3Q earnings than analysts had expected despite seeing higher-than-expected acuity--a measure of illness severity--in its Medicaid patient population after redeterminations, Mizuho analyst Ann Hynes says in a research note. The company's strong position in the individual marketplace continues to offset these Medicaid pressures, the analyst says. The managed healthcare provider delivered a solid quarter in contrast to its peers' results, which seem to have spooked investors, Hynes says. Centene's stock fell 23% between Sept. 1 and this morning's earnings release. Cost trends will be a main focus of management's call with analysts, Hynes says. Shares rise 11% to $68.53. (dean.seal@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 25, 2024 10:06 ET (14:06 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Centene Outperformed Despite Higher Medicaid Acuity -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCentene Outperformed Despite Higher Medicaid Acuity -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-25 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1006 ET - Centene logged better 3Q earnings than analysts had expected despite seeing higher-than-expected acuity--a measure of illness severity--in its Medicaid patient population after ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AYI","symbol_name":"Acuity Brands Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2478365389","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478365389","pubTimestamp":1729865160,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1006 ET - Centene logged better 3Q earnings than analysts had expected despite seeing higher-than-expected acuity--a measure of illness severity--in its Medicaid patient population after redeterminations, Mizuho analyst Ann Hynes says in a research note. The company's strong position in the individual marketplace continues to offset these Medicaid pressures, the analyst says. The managed healthcare provider delivered a solid quarter in contrast to its peers' results, which seem to have spooked investors, Hynes says. Centene's stock fell 23% between Sept. 1 and this morning's earnings release. Cost trends will be a main focus of management's call with analysts, Hynes says. Shares rise 11% to $68.53. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"AYI":"Acuity Brands Inc","CNC":"康西哥"},"translate_title":"尽管医疗补助敏感度较高，Centene仍表现出色——市场讨论","themeId":"309a0b3ff36ca7aefb034f2689a0726b","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AYI":1,"CNC":1},"content_text":"1006 ET - Centene logged better 3Q earnings than analysts had expected despite seeing higher-than-expected acuity--a measure of illness severity--in its Medicaid patient population after redeterminations, Mizuho analyst Ann Hynes says in a research note. The company's strong position in the individual marketplace continues to offset these Medicaid pressures, the analyst says. The managed healthcare provider delivered a solid quarter in contrast to its peers' results, which seem to have spooked investors, Hynes says. Centene's stock fell 23% between Sept. 1 and this morning's earnings release. Cost trends will be a main focus of management's call with analysts, Hynes says. Shares rise 11% to $68.53. (dean.seal@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 25, 2024 10:06 ET (14:06 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478365389"}